Introduction
Lipid homeostasis significantly changes during pregnancy to ensure adequate nutritional support to the foetus. This includes an average 2-4-fold increase in triglycerides by the third trimester. Usually, this is well tolerated by women with normal baseline triglyceride levels and metabolic pathways [1]. However, in the presence of genetic abnormalities affecting triglyceride metabolism or secondary exacerbating factors such as medications or uncontrolled diabetes; severe gestational hypertriglyceridaemia can occur [2]. This poses significant maternal and foetal risk, including that of acute pancreatitis, hyperviscosity syndrome and pre-eclampsia [3, 4]. Although requiring aggressive treatment to optimise outcomes, the existing management practices rely on observational data and case reports, revealing a gap in the available literature [5].
Case Report
We report the case of a 39-year-old female, G4P2T1 31+5 weeks gestation, living in regional Queensland. She was transferred to a rural tertiary referral centre with Maternal Foetal Medicine and Obstetric Medicine expertise after an incidental finding of severe hypertriglyceridaemia [41.4mmol/L (<1.5mmol/L)] on routine bloods. Her pregnancy-related complications included a new diagnosis of both pre-eclampsia and diet-controlled gestational diabetes mellitus (GDM), with a large for gestational age (LGA) foetus on a 31-week ultrasound, measuring at the 93rd centile. She was also treated with therapeutic enoxaparin after a presentation with pulmonary embolism at 27-weeks gestation. Her past medical history is pertinent for class III obesity and smoking.
On admission, she was commenced on a low fat, low carbohydrate diet and high dose fish oil two grams twice daily. She declined fibrate therapy. She was placed on an insulin infusion, titrated to 3-5 units per hour according to her blood glucose readings, with 5% dextrose as background maintenance fluids. There was initial improvement of her triglycerides to a nadir at 18.7mmol/L and a decision was made to commence plasmapheresis at 32+4 weeks. She required three plasmapheresis sessions before being successfully discharged at 33+3 weeks gestation with triglycerides of 5.7mmol/L. She was regularly monitored in the community, with weekly plasmapheresis sessions aiming to maintain triglycerides to less than 11mmol/L. Her blood pressure remained well controlled on anti-hypertensives during this period. She went on to deliver a healthy term infant at 37+0 weeks gestation via an elective repeat lower uterine caesarean section.
Discussion Points